Read more on Biosimilar Interchangeability Requirements and Pharmacist Resources
PDTs offer significant promise in treating certain conditions and improving access to care, but participants
agreed that a new modality requires new approaches to coverage. This brief is intended to help prepare the American health care system to begin covering PDTs.
Host Fred Goldstein invites Jennifer Mathieu, Senior Vice President, Professional & Government Affairs to discuss the Prescription Digital Therapeutics Act, the Medicaid MVPs for Patient Act and other AMCP legislative priorities.